CBT — Stock Film
STOCK FILMSCENE 1/11CBT · $88.89
Stock Expert AI presents
CBT
Cabot Corp
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Cabot Corp. A quick introduction.

On the stock market since 1980, it operates in the world of raw materials. It has 4,064 employees. Now — the numbers.

on the stock market since 1980
4,064 employees
$4.6B market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $9 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 9%

This is an established company with proven profits.

WHERE DOES THE MONEY COME FROM?
65%Reinforcement Materials
Reinforcement Materials 65%Performance Chemicals 35%
65% of all revenue comes from a single line: Reinforcement Materials.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

Cash on hand:
$0
Total debt:
$0
The debt outweighs the cash.

The gap is $957M. In times of high interest rates, a gap like that can squeeze a company.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
81
very strong

Profit power and business quality lead the class.

FINANCIAL STRENGTH
52
average

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
92
very strong

The price looks reasonable next to what the company earns.

GROWTH
63
average

There is growth, but not at top-of-the-class tempo.

PRICE MOMENTUM
83
very strong

The stock has been running stronger than the market lately.

No real weak spot in any of the five subjects — a balanced report card.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 3 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Few are betting against it10/10
WEAK SPOTS
Growth has stalled2/10
Little set aside for the future2/10
WORTH WATCHING

Revenue Growth: Sales are growing slowly.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 24% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/3
Delivers on expectations

It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.

2
THE BRIGHT SIDE · 2/3
Executives are buying their own stock

Over the last 12 months, company executives reported 77 buys and 17 sells. Management buying with its own money is usually read as a good sign.

3
THE BRIGHT SIDE · 3/3
Pays a steady dividend

It pays out $1.82 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/3
Sales are shrinking

Over the last 3 years, sales fell about 5% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.

2
THE RISKS · 2/3
Growth has stalled

The sales tempo runs behind the sector. Council score: 2/10. The high “Growth” grade on the report card comes from profit power instead.

3
THE RISKS · 3/3
Little set aside for the future

The share set aside for the future is small; the pace of new ideas may slow. Council score: 2/10.

FINALE · THE GRADE
A
0 / 100 · MoonshotScore

On our five-subject report card, CBT sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”

The takeaway: CBT is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film